Business
Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.
Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc..
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.\nCanada NewsWire\nOTTAWA, ON, Nov. 2, 2020\n\n\n\nOTTAWA, ON, Nov. 2, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX: TBP) (OTCQB: TBPMF) is pleased to announce that on October 27, 2020, it acquired 14,625,000 common shares (the \"Acquired Shares\") of Mondias Natural Products Inc. (\"Mondias\"), a corporation with its head office at #26 – 4500 Kimber Boulevard Saint-Hubert, QC, J3Y 8K5. The Acquired Shares were acquired by Tetra in connection with the previously announced divesture of Tetra's former subsidiary, Lumiera Health Innovation Inc. (the \"Target\"), pursuant to which Mondias has acquired all of the common shares of the Target for a purchase price of CAN$1.3 million (the \"Lumiera Transaction\"). The portion of the purchase price for the Lumiera Transaction payable to Tetra was paid through the issuance of the Acquired Shares.\nTetra did not hold any securities in the capital of Mondias prior to the date of the Lumiera Transaction. The Acquired Shares represent approximately 14.8% of the issued and outstanding shares of Mondias following the closing of the Lumiera Transaction.\nTetra has acquired the Acquired Shares for investment purposes and may acquire further securities of Mondias or dispose of its holdings of common shares of Mondias, both as investment conditions warrant. The common shares of Mondias are listed on the TSX Venture Exchange under the symbol \"NHP\". \nTetra's head office is located at 2316 St-Joseph Blvd., Orleans, ON, K1C 1E8. For further information please contact Jean-François Boily, Chief Financial Officer of Tetra, at [email protected].\nAbout Tetra Bio-Pharma\nTetra Bio-Pharma (TSX:TBP) (OTCQB:TBPMF), is a biopharmaceutical leader in cannabinoid-based drug discovery and development with FDA and Health Canada approved clinical programs aimed at bri...